# BIOCRYST PHARMACEUTICALS INC (BCRX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 09058V103
Page URL: https://superinvestorclub.com/stock/BCRX
Last updated: 2026-07-08T13:36:51.180Z

## Summary

As of the most recent 13F filing period, BIOCRYST PHARMACEUTICALS INC (BCRX) is held by 1 tracked superinvestors with an aggregate position value of $6.1M representing 0638054 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 638054 | $6.1M | 0.03% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2025-09-30: 1 holders, $3.1M aggregate, 0411503 shares
- 2025-12-31: 1 holders, $1.8M aggregate, 0235572 shares
- 2026-03-31: 1 holders, $6.1M aggregate, 0638054 shares

## Recent congressional trades (1)

- 2025-11-13: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000

## Recent insider transactions (0)


## Citation

When citing, use: "BIOCRYST PHARMACEUTICALS INC (BCRX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/BCRX), aggregating SEC 13F, Form 4, and congressional disclosures."